Bioventus Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BVS research report →
About the company
Bioventus Inc. , a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle.
- CEO
- Robert Claypoole
- IPO
- 2021
- Employees
- 930
- HQ
- Durham, NC, US
Price Chart
- Market Cap
- $710.00M
- P/E
- 24.75
- P/S
- 1.23
- P/B
- 3.73
- EV/EBITDA
- 9.16
- Div Yield
- 0.00%
- Gross Margin
- 67.78%
- Op Margin
- 10.64%
- Net Margin
- 4.94%
- ROE
- 16.27%
- ROIC
- 11.77%
- Revenue
- $568.09M · -0.91%
- Net Income
- $22.73M · 167.77%
- EPS
- $0.34 · 165.38%
- Op Income
- $58.55M
- FCF YoY
- 88.98%
- 52W High
- $11.25
- 52W Low
- $5.81
- 50D MA
- $9.57
- 200D MA
- $8.30
- Beta
- 0.67
- Avg Volume
- 601.64K
Get TickerSpark's AI analysis on BVS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 2, 26 | Bartholdson John A. | other | 32,282 |
| Jun 3, 26 | Bartholdson John A. | other | 25,146 |
| Jun 2, 26 | Bartholdson John A. | other | 32,282 |
| Jun 2, 26 | SUTTER MARTIN P | other | 32,282 |
| Jun 3, 26 | SUTTER MARTIN P | other | 25,146 |
| Jun 2, 26 | SUTTER MARTIN P | other | 32,282 |
| Jun 2, 26 | STALNECKER SUSAN M | other | 32,282 |
| Jun 3, 26 | STALNECKER SUSAN M | other | 25,146 |
| Jun 2, 26 | STALNECKER SUSAN M | other | 32,282 |
| Jun 2, 26 | NOHRA GUY P | other | 32,282 |
Our BVS coverage
Recent articles, reports, and earnings notes.
No research on BVS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BVS report →Similar companies
Peers in the same neighborhood.